Pfizer says its vaccine for the Wuhan virus is more than 90% effective. Is the wait for vaccines now finally over? Will you be able to get a shot soon? Is the Pfizer vaccine safe? WION's Palki Sharma tells you all that you need to know.

Gravitas: Pfizer vaccine is 90% effective: All you need to know

Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many questions remain unanswered.

Pfizer vaccine news sends stock markets soaring

The experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE may not be coming to local pharmacies for the general public any time soon. The vaccine's complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.

Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon

Positive data on BioNTech and US partner Pfizer Inc's COVID-19 vaccine came as a happy surprise for not only the world, but also the married couple behind the German biotech firm.

Of the 'dream team': The married couple behind Pfizer's Covid vaccine

US President Donald Trump on Monday accused the Food and Drug Administration (FDA) and Pfizer of withholding the announcement on the COVID-19 vaccine before elections to prevent him from getting a "vaccine win".

Trump accuses FDA and Pfizer of withholding COVID-19 vaccine announcement before elections

Pfizer Inc said on Monday its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a pandemic that has killed more than a million people, battered the world's economy and upended daily life.

Pfizer, BioNTech claim their coronavirus vaccine is 90% effective

US pharmaceutical giant Pfizer is planning to file for emergency use authorisation for its Covid-19 vaccine in late November -- two weeks after the November 3 US presidential election.

Pfizer plans to seek authorisation for Covid vaccine in November

US corporation Pfizer said today that it would be conducting coronavirus vaccine trial which will include adolescents as young as 12. Also Read: World Bank approves $12 billion for COVID-19 vaccines Pfizer's Rod MacKenzie in a tweet said that the move has been approved by the US Food and Drug Association(FDA).

Pfizer to start coronavirus vaccine tests on children as young as 12

US drugmaker Pfizer's chief Albert Bourla on Sunday said it is ''likely'' the coronavirus vaccine will be deployed to all Americans by the end of this year. Pfizer and its partner BioNTech hope to wrap up final-stage Phase III trials of their Covid-19 vaccine candidate as early as next month.

Americans can get COVID-19 vaccine before year-end, says Pfizer CEO

After Russia, these COVID-19 vaccines set to unveil soon!

US drugmaker Pfizer Inc said on Wednesday it was shutting down two manufacturing plants in India that make generic injectables like penicillin in response to falling demand.

Pfizer to shut two manufacturing plants in India

The drugmaker has decided not to separate its low-growth generics from its patent-protected branded medicines

Pfizer decides not to split into two

The company sells most of its top 20 global products in India

Pfizer plans to bring more global drugs to India

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news